Par acquiring generics company Edict for up to $37.6M in cash

Edict Pharmaceuticals Pvt. Ltd.

India / Private Biopharma

Seller

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Par Pharmaceutical Cos. Inc.

U.S. / Small-Cap Biopharma (<$1 billion)

Buyer

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Completed

Sample

01/01/2009

announced

01/01/2009

completed